Symptoms that mimic fibroids make diagnosing uterine sarcoma a rare and confounding cancer. In 2014, Dionne Shepperson, then 40 and pregnant, began feeling weak and faint. Because she had in the past ...
GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and CA125. GDF15 serves as an independent prognostic factor for ...
Uterine sarcomas are rare, aggressive tumors with limited chemotherapy responsiveness. Poly(ADP-ribose) polymerase inhibitors (PARPis) have emerged as targeted therapies for patients with BRCA ...
Recent advances in the biological and molecular understanding of rare uterine tumors have expanded therapeutic options for patients. Uterine cancers are a highly heterogeneous group of cancers that ...
JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Endometrial stromal sarcoma (ESS) is a rare uterine malignancy originating from endometrial connective tissue. It is classified into benign and malignant subtypes. While it primarily affects ...
The molecular heterogeneity of endometrial stromal tumors (ESTs) is demonstrated by the presence of the same fusion gene in distinct pathologic entities, such as endometrial nodules and low-grade ...
Following the tragic passing of inspirational cancer campaigner Vicky Phelan, aged 42, awareness is more crucial than ever for this rare and aggressive form of uterine cancer. Uterine leiomyosarcoma ...
The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results